Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment

Abstract Rationale Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease pathogenesis. In clinical practice, trained readers will visually categorise positron emission tomography (PET) scans as either Aβ positive or negative. However, adjunct quantitative an...

Full description

Bibliographic Details
Main Authors: Hugh G. Pemberton, Christopher Buckley, Mark Battle, Ariane Bollack, Vrajesh Patel, Petya Tomova, David Cooke, Will Balhorn, Katherine Hegedorn, Johan Lilja, Christine Brand, Gill Farrar
Format: Article
Language:English
Published: SpringerOpen 2023-05-01
Series:EJNMMI Research
Subjects:
Amyloid PET
SUVr
Alzheimer’s
MCI
Quantification
[18F]flutemetamol
Online Access:https://doi.org/10.1186/s13550-023-00994-3

Internet

https://doi.org/10.1186/s13550-023-00994-3

Similar Items